21133728Liu H, Artz ASLeukemia & lymphomaAntineoplastic Agents; Biliopancreatic Diversion; Gastric Bypass; Intestinal Absorption; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; PyrimidinesBenzamides; Female; Humans; Imatinib Mesylate; Intestinal Diseases; Middle Aged; ObesityReduction of imatinib absorption after gastric bypass surgery. Leuk Lymphoma. 2011 Feb; 52(2):310-3.Leuk Lymphoma2010-12-06T00:00:002010Reduction of imatinib absorption after gastric bypass surgery.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD001549Chemicals & Drugs942260.914065BenzamidesD009765Disorders3489620.602562ObesityAuthorship 1259511D007410Disorders51790.927605Intestinal DiseasesD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleAuthorship 43294D010879Chemicals & Drugs1102720.858215PiperazinesD007408Physiology471230.950544Intestinal AbsorptionD006801Living Beings2262862810.130052HumansMedicine-Hematology and OncologyD015904Procedures440.993089Biliopancreatic Diversion0.3975290.1987642authors10.2514has subject areaD011743Chemicals & Drugs1373700.795259PyrimidinesD000068877451260.961421Imatinib MesylateD015390Procedures451100.88715Gastric BypassD015464Disorders401730.886112Leukemia, Myelogenous, Chronic, BCR-ABL PositiveUniversity of ChicagoHongtaoLiu325gHvU1DO/RmHllZ0mg9mHvHongtao Liu41.78927490000000-87.60125000000000199Liu, HongtaoAssociate Professortrue1Associate ProfessorAssociate Professor